pharma · Patency of the Ductus Arteriosus · Atopic Dermatitis · CNTB
S.L
S.L is a pharma organization headquartered in SAN DIEGO, CA, EU. It trades on NYSE under ticker CNTB. Primary therapeutic focus areas include Patency of the Ductus Arteriosus, Atopic Dermatitis, Chronic Rhinosinusitis Wi
SAN DIEGO, CA, EU HQ
Public company Type
CNTB · NYSE Ticker
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, EU
- Programs
- 15
- Drugs
- 11
- Patents
- 179
CBP-307
Phase 1 · small molecule · Autoimmune Diseases
CBP-307 for Autoimmune Diseases is a Phase 1 program (small_molecule) at S.L with 2 ClinicalTrials.gov record(s).
Internal code CBP-307AU002
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- S.L
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Autoimmune Diseases
- Status
- completed
- Trials
- 2